Начало・Списък с акции・Medpace Holdings Inc

Medpace Holdings Inc

Отворен

СекторЗдравеопазване

579.14 -1.03

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

565.71

Максимум

592.34

Ключови измерители
By Trading Economics
Приходи	-2.5M 121M
Продажби	727K 707M
P/E Средно за сектора	35.334 64.641
EPS	4.25
Марж на печалбата	17.158
Служители	6,500
EBITDA	-21M 134M

Препоръки
By TipRanks
Препоръки	Неутрален
12-месечна прогноза	-0.81% downside

Дивиденти
By Acuity
Следващи печалби	21.10.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	1.4B 16B
Предишно отваряне	580.17
Предишно затваряне	579.14

Настроения в новините

By Acuity

50%

158 / 340 Класиране в Healthcare

Medpace Holdings Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

29.07.2026 г., 18:44 ч. UTC

Macro Event

Medpace Holdings Inc. is trading higher, buoyed by the Federal Reserve's steady interest rates, despite broader market pressures from rising oil prices and geopolitical tensions.

28.07.2026 г., 23:11 ч. UTC

Medpace Holdings Inc shares are higher in after-market hours, rebounding after four consecutive lower closes and remaining above the 20-day moving average.

27.07.2026 г., 16:56 ч. UTC

News

Medpace Holdings Inc. shares are lower amid broader market volatility, despite reporting strong Q2 2026 business awards and raising guidance.

24.07.2026 г., 18:26 ч. UTC

News

Analyst upgrades from RBC Capital and Truist Securities boost Medpace Holdings' price targets, contributing to modest gains during Friday's trading session.

22.07.2026 г., 23:22 ч. UTC

Social Media

News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

21.07.2026 г., 19:46 ч. UTC

News

Medpace Holdings Inc. shares rise as analysts project 14.3% revenue growth ahead of Wednesday's Q2 earnings report, following a $706.6 million revenue last year.

Сравнение с други в отрасъла

Ценова промяна

Medpace Holdings Inc Прогноза

Ценова цел

By TipRanks

-0.81% надолу

12-месечна прогноза

Среден 580.2 USD -0.81%

Висок 692 USD

Нисък 450 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за Medpace Holdings Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

11 ratings

Купи

Задържане

Продай

Според 11 анализатори, дали борсови рейтинги на Medpace Holdings Inc през последните 3 месеца.

Настроение

By Acuity

158 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.